Stay updated on PK and QTc Interaction in Sitravatinib Clinical Trial

Sign up to get notified when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PK and QTc Interaction in Sitravatinib Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T02:07:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2; no changes to core content, trial data, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-16T16:22:23.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed outdated notices for Revision: v3.4.0 and the government funding lapse notice; operating status references were updated.
    Difference
    0.4%
    Check dated 2026-02-09T13:37:20.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    UI changes include showing the glossary and minor labeling tweaks (e.g., capitalization of 'Met QC Criteria' and 'No FEAR Act Data'). The revision was updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-26T09:54:02.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows an updated revision line: Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be a minor internal version update with no changes to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-01-19T07:35:59.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added Location sections for Indiana, Texas, Virginia, and Washington and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the prior Indiana, Texas, Virginia, and Washington location listings.
    Difference
    0.5%
    Check dated 2025-12-21T21:53:11.000Z thumbnail image

Stay in the know with updates to PK and QTc Interaction in Sitravatinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.